Stocks
Funds
Screener
Sectors
Watchlists

Latest Blue Water Life Science Advisors, LLC Stock Portfolio

Blue Water Life Science Advisors, LLC Performance:
2024 Q3: 15.11%YTD: 11.12%2023: -11.29%

Performance for 2024 Q3 is 15.11%, and YTD is 11.12%, and 2023 is -11.29%.

About Blue Water Life Science Advisors, LLC and 13F Hedge Fund Stock Holdings

In it's latest 13F Holdings report, Blue Water Life Science Advisors, LP reported an equity portfolio of $113.7 Millions as of 30 Sep, 2024.

The top stock holdings of Blue Water Life Science Advisors, LP are NTRA, CDNA, EXAS. The fund has invested 32.5% of it's portfolio in NATERA INC and 16.6% of portfolio in CAREDX INC.

The fund managers got completely rid off 10X GENOMICS INC (TXG) and MAXCYTE INC (MXCT) stocks. They significantly reduced their stock positions in QUANTERIX CORP (QTRX), NATERA INC (NTRA) and GUARDANT HEALTH INC (GH). Blue Water Life Science Advisors, LP opened new stock positions in ADAPTIVE BIOTECHNOLOGIES COR (ADPT) and PERSONALIS INC (PSNL). The fund showed a lot of confidence in some stocks as they added substantially to EXACT SCIENCES CORP (EXAS) and CAREDX INC (CDNA).

Blue Water Life Science Advisors, LLC Annual Return Estimates Vs S&P 500

Our best estimate is that Blue Water Life Science Advisors, LP made a return of 15.11% in the last quarter. In trailing 12 months, it's portfolio return was 25.28%.

New Buys

Ticker$ Bought
adaptive biotechnologies cor10,983,100
personalis inc5,380,000

New stocks bought by Blue Water Life Science Advisors, LLC

Additions

Ticker% Inc.
exact sciences corp345
caredx inc18.43

Additions to existing portfolio by Blue Water Life Science Advisors, LLC

Reductions

Ticker% Reduced
quanterix corp-71.84
natera inc-42.14
guardant health inc-21.01

Blue Water Life Science Advisors, LLC reduced stake in above stock

Sold off

Ticker$ Sold
maxcyte inc-2,367,430
10x genomics inc-4,473,500

Blue Water Life Science Advisors, LLC got rid off the above stocks

Sector Distribution

Blue Water Life Science Advisors, LP has about 100% of it's holdings in Healthcare sector.

Sector%
Healthcare100

Market Cap. Distribution

Blue Water Life Science Advisors, LP has about 47.8% of it's portfolio invested in the large-cap and mega-cap stocks.

Category%
LARGE-CAP47.8
SMALL-CAP27.1
MICRO-CAP16
MID-CAP9.1

Stocks belong to which Index?

About 47.5% of the stocks held by Blue Water Life Science Advisors, LP either belong to S&P 500 or RUSSELL 2000 index.

Index%
Others52.5
RUSSELL 200047.5
Top 5 Winners (%)%
CDNA
caredx inc
80.2 %
EXAS
exact sciences corp
23.8 %
AKYA
akoya biosciences inc
16.2 %
ADPT
adaptive biotechnologies cor
12.5 %
NTRA
natera inc
12.4 %
Top 5 Winners ($)$
CDNA
caredx inc
8.4 M
NTRA
natera inc
6.8 M
EXAS
exact sciences corp
3.3 M
AKYA
akoya biosciences inc
1.8 M
ADPT
adaptive biotechnologies cor
1.2 M
Top 5 Losers (%)%
GH
guardant health inc
-16.4 %
QTRX
quanterix corp
-1.7 %
Top 5 Losers ($)$
GH
guardant health inc
-2.7 M
QTRX
quanterix corp
-0.1 M

Blue Water Life Science Advisors, LLC Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of Blue Water Life Science Advisors, LLC

Blue Water Life Science Advisors, LP has 8 stocks in it's portfolio. GH proved to be the most loss making stock for the portfolio. CDNA was the most profitable stock for Blue Water Life Science Advisors, LP last quarter.

Last Reported on: 14 Nov, 2024
TickerNamesorted ascending% PortfolioShares Held$ ValueType% ChangeOptions